A Computational Approach on Fenofibrate Drug Using Degree-Based Topological Indices and M-polynomials

Abstract

Fenofibrate is a drug approved by FDA Food and Drugs Administration used to treat patients with Hypertrigly ceridemia primary hypercholesterolemia or mixed dyslipidemia. It reduces low-density lipoprotein cholesterol (LDL-c), total cholesterol, triglycerides, and apolipoprotein B and increases high -density lipoprotein cholesterol (HDL-C) in adults. The sum and multiplicative versions of several topological indices such as General Zagreb, General Randic, Arithmetic Geometric Index, Inverse sum (Indeg) Index, Symmetric Division (Deg) Index, Forgotten Indices M-polynomials of Fenofibrate are computed in this article.